SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brad C. Dunlap who wrote (43)9/17/1996
From: I. Luttichuys   of 1762
 
Brad, Once again you have been more than informative. I really do appreciate receiving your input.
I was curious about what changes might be in store as concerns FDA approval of some therapies which, although not specifically directed against HIV itself, are nontheless targeted against the array of disease which HIV brings. We have more than one front with this one and I wondered if that's the way the FDA might see it. Anyway sounds like there is some effort in that direction.
I'm not too bent on relying on my aquaintance's views on what the Fed may or may not do but because of his background with respect to the Fed I give some attention on his predictions. Of course you are correct and one may as well rely on astrology to predict the Fed.
I am confident he may make a fool of me yet.
I also have seen some of Mr. Hecht's comment on IDEC and know that he has been excited about the company for some time. He must be gratified to see things coming around. I did not know, however, that Morgan Stanley is watching it. With all the news coming up, it is probably going to be an active couple of months.
Again, thanks for the great commentary.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext